Cannabis News
Analyzing the Relationship Between Cannabis and Schizophrenia in 2023
Published
2 years agoon
By
admin
In recent times, mental health conditions like schizophrenia have become a go-to scapegoat for those pushing for tighter cannabis regulations. Proponents of stricter rules often lean on personal stories and anecdotal evidence to make their case, advocating for things like THC caps or limits on how much cannabis people can buy. On the surface, these restrictions might seem like a reasonable way to protect public health. But when you dig a little deeper, you’ll see that they’re actually a sneaky attempt to limit our choices and freedoms when it comes to legal cannabis use.
Now, let’s talk about the supposed link between schizophrenia and cannabis. Time and time again, researchers have tried to pin down a causal relationship between the two. But guess what? In pretty much every study published on the subject, they’ve only managed to come up with correlational data – no smoking gun that proves one causes the other. This gray area leaves plenty of room for misinformation and manipulation, allowing those who favor stricter cannabis laws to exploit people’s fears about mental health disorders.
So, let’s dive into a recent article that tells the heart-wrenching tale of Cat Mayberry, a young woman who battled schizophrenia and eventually lost her life after struggling with cannabis addiction– at least according to her parents.
Through this story, we want to expose the tactics used to control the narrative around drug legalization and show why basing policy decisions on emotion-driven anecdotes isn’t the best approach.
By taking a closer look at the information in the article, we hope to spark a more well-rounded, evidence-based conversation about the intricate relationship between cannabis and mental health.
Now, I want to make it clear that I don’t stand in opposition of the Mayberry’s. What they experienced is horrific. The loss of a child is something that will break a person.
Therefore, I share their idea of increasing awareness, education, etc – but I believe it should be expanded to mental health in general.
We’ll explore how Schizophrenia works, and unpack different perspectives to get a nuanced view on this subject. I’ll remain respectful of the life of Catherine since I believe that this is an important topic, and that should be taken with the utmost care.
The Story of Cat
Before we dive into a deeper analysis, let’s first summarize the article in question, which tells the story of Cat Mayberry, a young woman who struggled with schizophrenia and addiction. This is a brief overview of Cat’s life, her transformation, and her parents’ accounts, featuring direct quotes from the article.
Cat Mayberry had been diagnosed with ADHD since an early age, and her parents, Trent and Jane, claim that she was a typical teenager. It wasn’t until college that things took a dark turn. In her freshman year, she began smoking cannabis, which her parents believe triggered her schizophrenia. Cat’s mental health rapidly deteriorated, and she was soon admitted to inpatient care for her condition.
According to her parents, the antipsychotic medications did not improve Cat’s mental health but made her feel numb and gain weight. Throughout her struggle with schizophrenia, Cat also continued to use marijuana. Her parents recalled that at one point, she would walk around with headphones on, playing music loudly to try to drown out the voices in her head. “That one she played over and over and over,” Jane said.
Cat went in and out of inpatient and outpatient care, and her parents eventually got her placed in supportive housing for people with severe mental illness. However, she had lost her old friends and developed an interest in body art, including getting piercings and tattoos. While living at Rising Cedar, the best supportive-housing facility in the Twin Cities, Cat was introduced to methamphetamine.
Her parents found her in an alley living in a tent with a homeless person after she mistakenly believed she had been kicked out of her apartment. Trent and Jane came to the devastating realization that their daughter’s life would never return to normal. As Trent put it, “Her brain was ruined at this point. We sensed it.”
Tragically, Cat was found dead at the age of 24, with a glass pipe and a packet of meth laced with fentanyl nearby. Her father, Trent, said, “I look at it as, God answered our prayers. We knew it was going to happen. It was just a matter of time. It happened at a point where our family was as strong as it could possibly be.”
Cat’s story has become a rallying cry for proponents of stricter cannabis regulations, as her parents believe that her marijuana use was the primary cause of her mental health issues. Trent said, “People can say, yeah, she died from a fentanyl overdose, but that’s not what really killed her. That’s what killed Cat. That’s not what killed Catherine. Catherine was killed by cannabis.”
This is the major sentiment from the article. The rest of the article provides “supporting evidence” in the form of studies, but as you’ll see later – these may not be the main area of concern.
Let’s begin breaking down what’s wrong with this perspective and how we can have a better approach to drug policy that will attempt to reduce the impact of addictive personalities, mental disorders, and how we as society deal with these issues.
Prohibition simply doesn’t work
Prohibition has been a historically ineffective method of regulating substances, and this holds true for cannabis as well.
As the tragic story of Cat Mayberry demonstrates, the answer to addressing cannabis-related issues is not through prohibition, but rather through education and understanding the risks associated with its use.
Even Cat’s parents recognize that prohibition was not the root of their daughter’s struggles, but rather a lack of education and awareness about the potential risks of using cannabis.
It’s crucial to remember that just like any other substance, cannabis can have different effects on individuals based on their unique biological makeup. For those with a predisposition to schizophrenia or other mental health issues, using high-potency cannabis products may exacerbate their conditions.
However, it’s unfair and unreasonable to limit the choices and rights of those who do not have such predispositions and can use cannabis products responsibly without negative consequences.
One possible approach to addressing this issue is to implement screening measures from a young age, which would help identify individuals who may be more susceptible to developing mental health issues when using cannabis. By doing so, families and individuals can be better prepared to navigate potential risks and make informed decisions about whether or not to use cannabis products.
Moreover, exploring alternative treatments for mental health conditions like schizophrenia can also contribute to a more comprehensive and compassionate approach to managing these issues.
For instance, holotropic breathwork, a technique that involves controlled breathing patterns, has shown promising results in helping individuals with schizophrenia (Garcia-Romeu, A., & Richards, W. A. (2017).
Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions. International Review of Psychiatry, 29(4), 331-341.). This method, along with other evidence-based treatments, could offer additional options for individuals struggling with mental health conditions, reducing the reliance on substances like cannabis as a coping mechanism.
It’s essential to acknowledge the complex relationship between cannabis use and mental health issues, and to approach this topic with nuance and empathy.
Rather than resorting to heavy-handed prohibition or restrictive regulation, we must focus on empowering individuals with the information and resources they need to make responsible choices about their cannabis use.
This includes increasing awareness about the potential risks associated with high-potency cannabis products for those predisposed to mental health issues, and supporting the development of alternative treatment options for those who need them.
The use of ADHD medications, particularly in children and adolescents, has been a topic of ongoing debate in the medical community. While these drugs have been proven to be effective in managing the symptoms of ADHD, there is still much to learn about the long-term effects of these medications on brain development. It’s worth noting that the conversation around the potential risks of these drugs is often overshadowed by the more prominent discussions surrounding cannabis.
ADHD medications, such as methylphenidate (Ritalin) and amphetamine (Adderall), are stimulants that work by increasing the levels of certain neurotransmitters in the brain. While these drugs can help improve focus and reduce impulsivity in individuals with ADHD, there are concerns about the potential impact of these medications on the developing brain.
A study by Andersen, S. L. (2005) published in the journal Neuropharmacology, raises concerns about the long-term consequences of using stimulant medications during critical periods of brain development. The study suggests that early exposure to these drugs may lead to alterations in the brain’s dopamine system, which could have implications for future vulnerability to substance abuse and other mental health issues. However, more research is needed to fully understand the implications of these findings.
Another area of concern is the potential link between ADHD medications and the development of schizophrenia or other psychotic disorders. A study by Moran, L. V., Ongur, D., Hsu, J., & Castro, V. M. (2019) published in JAMA Psychiatry found that amphetamines (such as Adderall) were associated with a higher risk of psychosis compared to methylphenidate (Ritalin). While the absolute risk of developing psychosis was still relatively low, the findings underscore the importance of carefully considering the potential risks and benefits of these medications when prescribing them to young patients.
Common side effects of ADHD medications include appetite suppression, sleep disturbances, headaches, and increased heart rate. These side effects can be concerning, especially when one considers that these drugs are being prescribed to children and adolescents whose brains are still developing.
It’s worth questioning why pharmaceutical drugs like ADHD medications are often “excluded” from the conversation when it comes to causality in the development of mental health issues, while cannabis takes center stage. Perhaps this is due to the fact that pharmaceutical drugs are heavily regulated and prescribed by medical professionals, whereas cannabis is still a controversial substance that is only recently gaining widespread acceptance for medicinal and recreational use.
Nonetheless, it’s essential to recognize that all substances, whether pharmaceutical or recreational, can carry risks and potential side effects, especially for those with pre-existing vulnerabilities or predispositions to mental health issues. A more balanced conversation that acknowledges the potential risks and benefits of all substances is necessary to make informed decisions about their use.
Mental illness is a complex and multifaceted issue that requires a comprehensive and nuanced understanding of its various causes and triggers. In cases like Cat’s, it’s all too easy for parents and society to pin the blame on a single substance, such as cannabis. However, it’s crucial to recognize that there are numerous factors that can contribute to the development and progression of mental illnesses like schizophrenia.
Schizophrenia, a severe mental health disorder characterized by delusions, hallucinations, and disorganized thinking, can be triggered by a variety of factors. These include genetic predisposition, environmental factors, brain chemistry imbalances, and substance abuse. Stressful life events, such as the death of a loved one, relationship issues, or the pressures of school and work, can also contribute to the onset of schizophrenia.
It’s essential to consider the broader context when examining the role of cannabis in cases like Cat’s. The suicide rate among individuals with schizophrenia is significantly higher than in the general population, and many people with the disorder turn to substances as a way of coping with their symptoms. Cat’s story, in which her struggles became more apparent during her college years, raises questions about the other potential factors that may have contributed to her mental health decline.
College can be a particularly challenging time for young adults as they navigate academic pressures, form new relationships, and experience a newfound sense of independence. These stressors, combined with a predisposition to mental illness, can act as triggers for the onset of schizophrenia or other psychotic disorders. In Cat’s case, it’s essential to consider the various factors that may have contributed to her struggles, rather than placing the blame solely on cannabis.
Where the focus should be, as Cat’s parents rightly emphasize, is on education. By providing individuals, particularly those at risk, with accurate information about the potential dangers of substance use, we can help them make informed decisions about their consumption. This approach acknowledges the need to protect vulnerable individuals without limiting the choices of those who can safely and responsibly use high-potency cannabis products.
Comparing the situation to the sale of peanut butter, which can be deadly for some people with allergies, offers an interesting perspective. Just as we don’t ban peanut butter for everyone because of the risk it poses to a small minority, we shouldn’t limit the availability of high-potency cannabis solely based on the potential risks to a specific subset of the population. Instead, we should focus on education and awareness to help those at risk make informed choices about their consumption.
In conclusion, mental illness is a complex issue that cannot be solely attributed to the use of cannabis or any other single factor. It’s crucial to examine the various triggers and contributing factors in cases like Cat’s, rather than placing the blame on a single substance. By focusing on education and awareness, we can help those at risk make informed decisions about their consumption, without limiting the choices and rights of others who can safely and responsibly use high-potency cannabis products. This approach promotes a more balanced and compassionate understanding of the challenges faced by individuals with mental illness and their families.
MARIJUANA AND SCHIZOPRENIA, READ ON…
DOES CANNABIS CAUSE SCHIZOPHRENIA IN PRE-DISPOSED PEOPLE?
You may like
Cannabis News
Latest Trump Weed Rumor – Trump Will Federally Deschedule and Decriminalize Cannabis, but Not Legalize It
Published
13 hours agoon
November 14, 2024By
admin
In a recent interview, former New Jersey Governor Chris Christie made headlines by asserting that President-elect Donald Trump will pursue significant reforms in federal policies regarding marijuana and cryptocurrency. As the nation grapples with evolving attitudes toward cannabis and the burgeoning digital currency market, Christie’s predictions have ignited discussions about the potential implications of such changes on both industries. This article delves into Christie’s insights, the current state of marijuana and cryptocurrency regulations, and the broader implications of these anticipated reforms.
The Current Landscape of Marijuana Legislation
Federal vs. State Laws
Marijuana remains classified as a Schedule I substance under the Controlled Substances Act (CSA), which places it in the same category as heroin and LSD. This classification has created a complex legal landscape where states have moved to legalize cannabis for medical and recreational use, while federal law continues to impose strict prohibitions. As of now, over 30 states have legalized marijuana in some form, leading to a burgeoning industry that generates billions in revenue.
Challenges Faced by the Cannabis Industry
Despite its legality in many states, the cannabis industry faces significant hurdles due to federal restrictions. These challenges include:
-
Banking Access: Many banks are hesitant to work with cannabis businesses due to fear of federal repercussions, forcing these businesses to operate largely in cash.
-
Taxation Issues: The IRS enforces Section 280E of the tax code, which prohibits businesses engaged in illegal activities from deducting normal business expenses, leading to disproportionately high tax burdens for cannabis companies.
-
Interstate Commerce: The lack of federal legalization prevents cannabis businesses from operating across state lines, limiting their growth potential.
Chris Christie’s Perspective on Marijuana Reform
Christie, a former presidential candidate known for his tough stance on drugs during his tenure as governor, has evolved his views on marijuana over the years. In his recent statements, he emphasized that Trump is likely to pursue descheduling cannabis, which would remove it from the Schedule I classification. This move would not only provide clarity for businesses operating in legal markets but also open avenues for banking and investment.
Christie highlighted that descheduling would allow for a more regulated market where safety standards could be established, thus protecting consumers. He believes that this approach aligns with a growing consensus among Americans who support legalization and recognize the potential benefits of cannabis use for both medical and recreational purposes.
The Future of Cryptocurrency Regulation = The Rise of Cryptocurrencies
Cryptocurrencies have surged in popularity over the past decade, with Bitcoin leading the charge as the first decentralized digital currency. The market has expanded to include thousands of alternative coins (altcoins), each with unique features and use cases. As cryptocurrencies gain traction among investors and consumers alike, regulatory scrutiny has intensified.
Current Regulatory Challenges
The cryptocurrency market faces several regulatory challenges that hinder its growth and adoption:
-
Lack of Clarity: Regulatory frameworks vary significantly across states and countries, creating confusion for investors and businesses.
-
Fraud and Scams: The rapid growth of cryptocurrencies has led to an increase in fraudulent schemes targeting unsuspecting investors.
-
Consumer Protection: Without clear regulations, consumers are often left vulnerable to risks associated with volatile markets.
Christie’s Vision for Crypto Regulation
Christie believes that under Trump’s leadership, there will be an effort to find a “sweet spot” for cryptocurrency regulation balancing innovation with consumer protection. He argues that overly stringent regulations could stifle growth in this emerging sector while too little oversight could expose consumers to significant risks.
In his view, a balanced regulatory framework would include:
1. Clear Definitions: Establishing clear definitions for different types of cryptocurrencies and tokens to differentiate between securities and utility tokens.
2. Consumer Protections: Implementing measures to protect investors from fraud while promoting transparency within the market.
3. Encouraging Innovation: Creating an environment conducive to innovation by allowing startups to thrive without excessive regulatory burdens.
Christie’s insights reflect a growing recognition among policymakers that cryptocurrencies are here to stay and that appropriate regulations are necessary to foster growth while safeguarding consumers.
Implications of Proposed Reforms
Economic Impact
The potential reforms proposed by Christie could have far-reaching economic implications:
-
Job Creation: Legalizing marijuana at the federal level could lead to significant job creation within the cannabis industry—from cultivation and production to retail sales.
-
Investment Opportunities: Descheduling cannabis would open up investment opportunities for institutional investors who have been hesitant due to federal restrictions.
-
Boosting Local Economies: Legal cannabis markets have proven beneficial for local economies through increased tax revenues and job creation.
Similarly, clear regulations around cryptocurrencies could stimulate investment in blockchain technology and related industries, fostering innovation and economic growth.
Social Justice Considerations
Both marijuana legalization and sensible cryptocurrency regulations have social justice implications:
-
Addressing Past Injustices: Legalizing marijuana could help rectify past injustices related to drug enforcement policies that disproportionately affected marginalized communities.
-
Financial Inclusion: Cryptocurrencies offer opportunities for financial inclusion for those underserved by traditional banking systems, particularly in low-income communities.
Political Landscape
The political landscape surrounding these issues is complex. While there is bipartisan support for marijuana reform among certain lawmakers, challenges remain in overcoming entrenched opposition. Similarly, cryptocurrency regulation has garnered attention from both sides of the aisle but requires collaboration to establish effective frameworks.
Conclusion
Chris Christie’s predictions about President-elect Donald Trump’s approach to federal marijuana descheduling and cryptocurrency regulation suggest a potential shift in U.S. policy that could significantly reshape both industries. As public opinion evolves on these issues, lawmakers have an opportunity to enact meaningful reforms that promote economic growth while ensuring consumer protection. The anticipated changes could foster a more robust cannabis industry that contributes positively to the economy and addresses social justice concerns, while clear regulatory frameworks for cryptocurrencies could encourage innovation and protect consumers in the digital economy. Stakeholders in both sectors are closely watching these developments, eager to see how potential reforms might impact their futures. While the realization of Christie’s predictions remains uncertain, it’s clear that the conversation around marijuana and cryptocurrency regulation is ongoing and far from settled.
TRUMP 2.0 ON CANNABIS REFORM, READ ON…
TRUMP 2.0 ON FEDERAL CANNABIS REFORM – WHAT DO WE KNOW?
Cannabis News
Webinar Replay: Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em
Published
2 days agoon
November 13, 2024By
admin
On Thursday, November 7th, Vince Sliwoski, Aaron Pelley and Fred Rocafort held a post election discussion “Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em”. Watch the replay!
Key Takeaways from the “Smoke ’em if You’ve Got ’em – 2024 Post Election Cannabis Wrap” Webinar:
- Panelists:
- Vince Sliwoski: Oregon Business lawyer specializing in cannabis and commercial real estate.
- Aaron Pelley: Experienced in cannabis law since Washington’s legalization in 2012.
- Fred Rocafort: Trademark attorney working closely with the cannabis team.
- Election Results Overview:
- Most 2024 cannabis ballot measures did not pass.
- Florida, South Dakota, and North Dakota saw failures.
- Nebraska became the 39th state to legalize cannabis for medical use when it passed two cannabis initiatives, Initiatives 437 and 438.
- Federal and State-Level Developments:
- Medical use is currently legal in 38 states, and 24 states allow recreational use.
- Republican support for marijuana legalization is growing.
- Federal Policy Implications:
- Schedule III Rescheduling: The process to move cannabis to Schedule III is ongoing, which could significantly impact the industry.
- Importance of Federal Appointments: The future of cannabis policy depends heavily on who is appointed to key positions in the administration.
- International and Domestic Trade:
- Schedule III status could ease import/export restrictions on cannabis.
- Unified control of House, Senate, and presidency might expedite legislative progress.
- Economic and Industry Impact:
- Cannabis stocks experienced volatility post-election, reflecting investor uncertainty.
- Federal legalization and banking reforms are crucial for industry stability and growth.
- Future Outlook:
- The potential for federal rescheduling remains strong, with hearings scheduled for early 2025.
- State-level initiatives and regulatory developments will continue to shape the industry.
“How Long Does One Puff of Weed Stay in Your System?”… This topic can be difficult to answer since it is dependent on elements such as the size of the hit and what constitutes a “one hit.” If you take a large bong pull then cough, it might linger in your system for 5-7 days. A moderate dose from a joint can last 3-5 days, whereas a few hits from a vaporizer may last 1-3 days.
The length of time that marijuana stays in the body varies based on a number of factors, including metabolism, THC levels, frequency of use, and hydration.
Delta-9-tetrahydrocannabinol, or THC, is the primary psychoactive component of cannabis. THC and its metabolites, which remain in your body long after the effects have subsided, are detected by drug tests.
Since these metabolites are fat-soluble, they cling to bodily fat molecules. They could thus take a while to fully pass through your system, particularly if your body fat percentage is higher.
THC is absorbed by tissues and organs (including the brain, heart, and fat) and converted by the liver into chemicals such as 11-hydroxy-THC and carboxy-THC. Cannabis is eliminated in feces at a rate of around 65%, while urine accounts for 20%. The leftover amount might be kept within the body.
THC deposited in bodily tissues ultimately re-enters the circulation and is processed by the liver. For frequent users, THC accumulates in fatty tissues quicker than it can be removed, thus it may be detectable in drug tests for days or weeks following consumption.
The detection time varies according to the amount and frequency of cannabis usage. Higher dosages and regular usage result in longer detection times.
The type of drug test also affects detection windows. Blood and saliva tests typically detect cannabis metabolites for shorter periods, while urine and hair samples can reveal use for weeks or even months. In some cases, hair tests have detected cannabis use over 90 days after consumption.
Detection Windows for Various Cannabis Drug Tests
Urine Tests
Among all drug tests, urine testing is the most commonly used method for screening for drug use in an individual.
Detection times vary, but a 2017 review suggests the following windows for cannabis in urine after last use:
– Single-use (e.g., one joint): up to 3 days
– Moderate use (around 4 times a week): 5–7 days
– Chronic use (daily): 10–15 days
– Chronic heavy use (multiple times daily): over 30 days
Blood Tests
Blood tests generally detect recent cannabis use, typically within 2–12 hours after consumption. However, in cases of heavy use, cannabis has been detected up to 30 days later. Chronic heavy use can extend the detection period in the bloodstream.
Saliva Tests
THC can enter saliva through secondhand cannabis smoke, but THC metabolites are only present if you’ve personally smoked or ingested cannabis.
Saliva testing has a short detection window and can sometimes identify cannabis use on the same day. A 2020 review found that THC was detectable in the saliva of frequent users for up to 72 hours after use, and it may remain in saliva longer than in blood following recent use.
In areas where cannabis is illegal, saliva testing is often used for roadside screenings.
Hair Tests
Hair follicle tests can detect cannabis use for up to 90 days. After use, cannabinoids reach the hair follicles through small blood vessels and from sebum and sweat surrounding the hair.
Hair grows at approximately 0.5 inches per month, so a 1.5-inch segment of hair close to the scalp can reveal cannabis use over the past three months.
Factors Affecting THC and Metabolite Retention
The length of time THC and its metabolites stay in your system depends on various factors. Some, like body mass index (BMI) and metabolic rate, relate to individual body processing, not the drug itself.
Other factors are specific to cannabis use, including:
– Dosage: How much you consume
– Frequency: How often you use cannabis
– Method of consumption: Smoking, dabbing, edibles, or sublingual
– THC potency: Higher potency can extend detection time
Higher doses and more frequent use generally extend THC retention. Cannabis consumed orally may remain in the system slightly longer than smoked cannabis, and stronger cannabis strains, higher in THC, may also stay detectable for a longer period.
How Quickly Do the Effects of Cannabis Set In?
When smoking cannabis, effects appear almost immediately, while ingested cannabis may take 1–3 hours to peak.
The psychoactive component THC produces a “high” with common effects such as:
– Altered senses, including perception of time
– Mood changes
– Difficulty with thinking and problem-solving
– Impaired memory
Other short-term effects can include:
– Anxiety and confusion
– Decreased coordination
– Dry mouth and eyes
– Nausea or lightheadedness
– Trouble focusing
– Increased appetite
– Rapid heart rate
– Restlessness and sleepiness
In rare cases, high doses may lead to hallucinations, delusions, or acute psychosis.
Regular cannabis use may have additional mental and physical effects. While research is ongoing, cannabis use may increase the risk of:
– Cognitive issues like memory loss
– Cardiovascular problems including heart disease and stroke
– Respiratory illnesses such as bronchitis or lung infections
– Mood disorders like depression and anxiety
Cannabis use during pregnancy can negatively impact fetal growth and development.
Duration of Effects
Short-term effects generally taper off within 1–3 hours, but for chronic users, some long-term effects may last days, weeks, or even months. Certain effects may even be permanent.
Bottom Line
The amount of time that cannabis remains in your system following a single use varies greatly depending on individual characteristics such as body fat, metabolism, frequency of use, and mode of intake. Frequent users may maintain traces of THC for weeks, whereas infrequent users may test positive for as little as a few days. Hair tests can disclose usage for up to 90 days, while blood and saliva tests identify more recent use. Urine tests are the most popular and have varying detection durations. The duration that THC and its metabolites are detectable will ultimately depend on a number of factors, including dose, strength, and individual body chemistry.
PEE IN A CUP COMING UP, READ ON..
Latest Trump Weed Rumor – Trump Will Federally Deschedule and Decriminalize Cannabis, but Not Legalize It
Webinar Replay: Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em
I Had Just One Puff
Marijuana firms Eaze, Green Dragon find new life after $10 million capital infusion
Get some rest on Modified Grapes—November’s Leafly HighLight
Is Kratom Addictive? Understanding Dependence, Risks, and Safe Usage
New Rule, December 5: Oregon Cannabis Retailers, Processors and Labor Peace Agreements
The CBD Dog Treat Guide
Trippin’ Golf Balls – Can Magic Mushrooms Help Your Golf Game?
Australian Broadcasting Corp Alleges Military Veterans Have Been Targeted By Medicinal Cannabis Companies Via Social Media & Offered Free “Product”
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
UArizona launches online cannabis compliance online course
Trending
-
Cannabis News2 years ago
Distressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years ago
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years ago
What you Need to Know
-
drug testing11 months ago
Drug Testing for Marijuana – The Joint Blog
-
Education2 years ago
NCIA Write About Their Equity Scholarship Program
-
Cannabis2 years ago
It has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years ago
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years ago
A new April 20 cannabis contest includes a $40,000 purse